{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:13:38Z","timestamp":1774368818835,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Portuguese Foundation of Science and Technology","award":["PTDC\/SAU-MET\/121133\/2010"],"award-info":[{"award-number":["PTDC\/SAU-MET\/121133\/2010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12020-016-0893-x","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T06:03:24Z","timestamp":1455775404000},"page":"433-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Hyperresistinemia and metabolic dysregulation: a risky crosstalk in obese breast cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Joana","family":"Cris\u00f3stomo","sequence":"first","affiliation":[]},{"given":"Paulo","family":"Matafome","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Santos-Silva","sequence":"additional","affiliation":[]},{"given":"Ana L.","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Patr\u00edcio","sequence":"additional","affiliation":[]},{"given":"Liliana","family":"Letra","sequence":"additional","affiliation":[]},{"given":"Ana B.","family":"Sarmento-Ribeiro","sequence":"additional","affiliation":[]},{"given":"Lelita","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Sei\u00e7a","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"key":"893_CR1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/gme.0b013e3181788d88","volume":"15","author":"VG Vogel","year":"2008","unstructured":"V.G. Vogel, Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer. Menopause 15, 782\u2013789 (2008)","journal-title":"Menopause"},{"key":"893_CR2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, M. Zwahlen, Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569\u2013578 (2008)","journal-title":"Lancet"},{"key":"893_CR3","first-page":"34","volume":"20","author":"M Dalamaga","year":"2013","unstructured":"M. Dalamaga, Obesity, insulin resitance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets. World J. Exp. Med. 20, 34\u201342 (2013)","journal-title":"World J. Exp. Med."},{"key":"893_CR4","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1530\/ERC-11-0374","volume":"19","author":"DH Cohen","year":"2012","unstructured":"D.H. Cohen, D. LeRoith, Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr. Relat. Cancer 19, F27\u2013F45 (2012)","journal-title":"Endocr. Relat. Cancer"},{"key":"893_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/dmrr.2395","volume":"29","author":"P Matafome","year":"2013","unstructured":"P. Matafome, D. Santos-Silva, C.M. Sena, R. Sei\u00e7a, Common mechanisms of dysfunctional adipose tissue and obesity-related cancers. Diabetes Metab. Res. Rev. 29, 285\u2013295 (2013)","journal-title":"Diabetes Metab. Res. Rev."},{"key":"893_CR6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/erc.1.00729","volume":"13","author":"AM Lorincz","year":"2006","unstructured":"A.M. Lorincz, S. Sukumar, Molecular links between obesity and breast cancer. Endocr. Relat. Cancer 13, 279\u2013292 (2006)","journal-title":"Endocr. Relat. Cancer"},{"key":"893_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1158\/1940-6207.CAPR-12-0091","volume":"5","author":"GL Anderson","year":"2012","unstructured":"G.L. Anderson, M.L. Neuhouse, Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev. Res. 5, 515\u2013521 (2012)","journal-title":"Cancer Prev. Res."},{"key":"893_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/157339912799424519","volume":"8","author":"L Vona-Davis","year":"2012","unstructured":"L. Vona-Davis, D.P. Rose, Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy. Curr. Diab. Rev. 8, 116\u2013130 (2012)","journal-title":"Curr. Diab. Rev."},{"key":"893_CR9","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1530\/ERC-12-0203","volume":"19","author":"DP Rose","year":"2012","unstructured":"D.P. Rose, L. Vona-Davis, The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr. Relat. Cancer 19, R225\u2013R241 (2012)","journal-title":"Endocr. Relat. Cancer"},{"key":"893_CR10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.20344\/amp.5180","volume":"27","author":"AT Tim\u00f3teo","year":"2014","unstructured":"A.T. Tim\u00f3teo, F. Miranda, M.M. Carmo, R.C. Ferreira, Optimal cut-off value for homeostasis model assessment (HOMA) index of insulin- resistance in a population of patients admitted electively in a portuguese cardiology ward. Acta Med. Port. 27, 473\u2013479 (2014)","journal-title":"Acta Med. Port."},{"key":"893_CR11","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association, Classification and diagnosis of diabetes. Diabetes Care 38, S8\u2013S16 (2015)","journal-title":"Diabetes Care"},{"key":"893_CR12","doi-asserted-by":"crossref","first-page":"s823","DOI":"10.1093\/ajcn\/86.3.823S","volume":"86","author":"F Xue","year":"2007","unstructured":"F. Xue, K.B. Michels, Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am. J. Clin. Nutr. 86, s823\u2013s835 (2007)","journal-title":"Am. J. Clin. Nutr."},{"key":"893_CR13","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00125-014-3361-2","volume":"57","author":"Y Huang","year":"2014","unstructured":"Y. Huang, X. Cai, M. Qiu, P. Chen, H. Tang, Y. Hu, Y. Huang, Prediabetes and the risk of cancer: a meta-analysis. Diabetologia 57, 2261\u20132269 (2014)","journal-title":"Diabetologia"},{"issue":"5","key":"893_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/bcr315","volume":"3","author":"NS Brown","year":"2001","unstructured":"N.S. Brown, R. Bicknell, Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3(5), 323\u2013327 (2001)","journal-title":"Breast Cancer Res."},{"key":"893_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","volume":"34","author":"HS Moon","year":"2013","unstructured":"H.S. Moon, M. Dalamaga, S.Y. Kim, S.A. Polyzos, O.P. Hamnvik, F. Magkos, J. Paruthi, C.S. Mantzoros, Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr. Rev. 34, 377\u2013412 (2013)","journal-title":"Endocr. Rev."},{"issue":"5","key":"893_CR16","doi-asserted-by":"crossref","first-page":"242S","DOI":"10.1038\/oby.2006.317","volume":"14","author":"RS Ahima","year":"2006","unstructured":"R.S. Ahima, Adipose tissue as an endocrine organ. Obesity 14(5), 242S\u2013249S (2006)","journal-title":"Obesity"},{"key":"893_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/bcr315","volume":"3","author":"NS Brown","year":"2001","unstructured":"N.S. Brown, R. Bicknell, Hypoxia and oxidative stress in breast cancer: Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3, 323\u2013327 (2001)","journal-title":"Breast Cancer Res."},{"key":"893_CR18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10549-010-0792-4","volume":"123","author":"CA Sun","year":"2010","unstructured":"C.A. Sun, M.H. Wu, C.H. Chu, Y.C. Chou, G.C. Hsu, T. Yang, YuCP Chou Wy, J.C. Yu, Adipocytokine resistin and breast cancer. Breast Cancer Res. Treat. 123, 869\u2013876 (2010)","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"893_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/bmm.13.99","volume":"8","author":"M Dalamaga","year":"2014","unstructured":"M. Dalamaga, Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives. Biomark. Med. 8(1), 107\u2013118 (2014)","journal-title":"Biomark. Med."},{"key":"893_CR20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ygyno.2012.02.032","volume":"125","author":"YC Lee","year":"2012","unstructured":"Y.C. Lee, Y.J. Chen, C.W. Chun, S. Lo, M.F. Hou, S.S. Yuan, Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification. Gynecol. Oncol. 125, 742\u2013750 (2012)","journal-title":"Gynecol. Oncol."},{"key":"893_CR21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/GME.0b013e31827f06dc","volume":"20","author":"M Dalamaga","year":"2013","unstructured":"M. Dalamaga, K. Karmaniolas, E. Papadavid, N. Pelekanos, G. Sotiropoulos, A. Lekka, Hyperresistinemia is associated with postmenopausal breast cancer. Menopause 20, 845\u2013851 (2013)","journal-title":"Menopause"},{"key":"893_CR22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clinbiochem.2013.01.001","volume":"46","author":"M Dalamaga","year":"2013","unstructured":"M. Dalamaga, G. Sotiropoulos, K. Karmaniolas, N. Pelekanos, E. Papadavid, A. Lekka, Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clin. Biochem. 46, 584\u2013590 (2013)","journal-title":"Clin. Biochem."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-0893-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0893-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T14:27:55Z","timestamp":1567607275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-0893-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-0893-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,18]]}}}